INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
14/12/2018
Voltar para busca
Dado oficial do USPTO
NDIFF
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
52
Atualização mais recente
14/12/2018
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
31/08/2006
Data de registro
29/04/2008
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/01/2018
Última transação
27/01/2018
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Shiga, JP
Examinador
KAJUBI, ELIZABETH N
Unidade examinadora
L70
Localização atual
TMEG LAW OFFICE 107
Titulares e representantes
Titulares
TAKARA BIO INC.
Stem Cell Sciences Holdings Limited
Stem Cell Sciences Holdings Limited
Representantes
Tracy-Gene G. Durkin Sterne, Kessler, Goldstein & Fox P.L.L.C.
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Reagents for scientific use in biological processing; biological preparations for scientific use in cell cultures; cultures of cell media for scientific use; media in the nature of buffer and standard solutions used in analytical chemistry for cell culture for use in scientific laboratories; media in the nature of buffer for scientific use; diagnostic preparations for scientific useantibodies; ELISA test kitsbiological reagents for use in enzyme linked immunosorbent assays for the biochemical detection of substances for scientific use; productskits containing antibodies for scientific use; tissue culture reagents for scientific and medical research use; cell culture reagents for scientific and medical research use; biological test kits composed of buffer and standard solutions used in analytical chemistryvectorscells and reagents for scientific and medical research use; cell culture media in the nature of buffer and standard solutions for scientific use
Classe 5
Biological reagents for medical use in embryology; biological reagents for medical purposes in the field of molecular biology; reagents for use in biological processing for medical purposes; reagents for use in biological processing for veterinary purposes; agents in the nature of hormonescytokinesantigens and immunoglobulins for activating cellular functions ; biological preparations for use in cell cultures for medical purposes; antitoxic sera; antitoxic sera for in-vivo use for medical purposes; antibodies for the treatment of disease; antibodies for immunodiagnostic medical purposes; antibodies for immunoprophylatic medical purposes; antibodies for immunotherapeutic medical purposes; antibodies for in-vivo use in detecting diseases in livestock; immunological antibodies for medical use; ELISA test kitsbiological reagents for use in enzyme linked immunosorbent assays for the biochemical detection of substances for medical and medical laboratory use; tissue culture reagents for medical and medical laboratory use; cell culture media in the nature of buffer and standard solutions for medical and medical laboratory use
Publicações
Histórico de despachos e eventos da marca no USPTO.
52 publicações encontradas
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
01/10/2018
INPC
INVALIDATION PROCESSED
01/10/2018
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
27/09/2018
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
27/01/2018
PRAN
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
27/01/2018
71AG
REGISTERED-SEC.71 ACCEPTED
27/01/2018
71AF
REGISTERED-SEC.71 FILED
25/01/2018
ES75
TEAS SECTION 71 & 15 RECEIVED
25/01/2018
CHLD
CHANGE OF OWNER RECEIVED FROM IB
31/08/2017
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
29/04/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
24/11/2016
RNWL
INTERNATIONAL REGISTRATION RENEWED
01/10/2016
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
10/07/2013
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
10/07/2013
715F
REGISTERED - SEC. 71 & SEC. 15 FILED
10/07/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/07/2013
ES75
TEAS SECTION 71 & 15 RECEIVED
05/07/2013
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
22/12/2012
FICS
FINAL DISPOSITION NOTICE SENT TO IB
18/08/2008
FIMP
FINAL DISPOSITION PROCESSED
18/08/2008
NREP
NEW REPRESENTATIVE AT IB RECEIVED
31/07/2008
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
29/07/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
29/04/2008
PUBO
PUBLISHED FOR OPPOSITION
12/02/2008
NPUB
NOTICE OF PUBLICATION
23/01/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/01/2008
ALIE
ASSIGNED TO LIE
07/01/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/11/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/10/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/10/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/10/2007
CPRA
PRIORITY ACTION MAILED
23/08/2007
CPRA
PRIORITY ACTION WRITTEN
23/08/2007
CNEA
EXAMINERS AMENDMENT MAILED
16/08/2007
XAEC
EXAMINER'S AMENDMENT ENTERED
15/08/2007
CNEA
EXAMINERS AMENDMENT -WRITTEN
15/08/2007
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/08/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/08/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/08/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/08/2007
ATRV
ATTORNEY REVIEW COMPLETED
02/03/2007
RFNT
REFUSAL PROCESSED BY IB
23/02/2007
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
12/02/2007
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
08/02/2007
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/02/2007
RFRR
REFUSAL PROCESSED BY MPU
01/02/2007
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/02/2007
CNRT
NON-FINAL ACTION WRITTEN
31/01/2007
DOCK
ASSIGNED TO EXAMINER
24/01/2007
NWAP
NEW APPLICATION ENTERED
05/01/2007
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/12/2006
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NDIFF ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.